메뉴 건너뛰기




Volumn 16, Issue 11, 2009, Pages 814-821

The disposition of hepatitis C antibody-positive patients in an urban hospital

Author keywords

Clinic attendance; Disposition; Hepatitis C; Race; Referral

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

EID: 70350009689     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01137.x     Document Type: Article
Times cited : (9)

References (22)
  • 1
    • 33646852746 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    • Armstrong GL, Wasley A, Simard EP et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006 144 : 705 714.
    • (2006) Ann Intern Med , vol.144 , pp. 705-714
    • Armstrong, G.L.1    Wasley, A.2    Simard, E.P.3
  • 2
    • 33846403737 scopus 로고    scopus 로고
    • Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
    • Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat 2007 14 : 107 115.
    • (2007) J Viral Hepat , vol.14 , pp. 107-115
    • Deuffic-Burban, S.1    Poynard, T.2    Sulkowski, M.S.3    Wong, J.B.4
  • 3
    • 0037387851 scopus 로고    scopus 로고
    • Projecting future complications of chronic hepatitis C in the United States
    • Davis GL, Albright JE, Cook S, Rosenberg D. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003 9 : 331 338.
    • (2003) Liver Transpl , vol.9 , pp. 331-338
    • Davis, G.L.1    Albright, J.E.2    Cook, S.3    Rosenberg, D.4
  • 4
    • 0037345681 scopus 로고    scopus 로고
    • Identification and management of hepatitis C patients in primary care clinics
    • Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 2003 98 : 639 644.
    • (2003) Am J Gastroenterol , vol.98 , pp. 639-644
    • Shehab, T.M.1    Orrego, M.2    Chunduri, R.3    Lok, A.S.4
  • 5
    • 33645087371 scopus 로고    scopus 로고
    • Clinical pathways for patients with newly diagnosed hepatitis C-what actually happens
    • Irving WL, Smith S, Cater R et al. Clinical pathways for patients with newly diagnosed hepatitis C-what actually happens. J Viral Hepat 2006 13 : 264 271.
    • (2006) J Viral Hepat , vol.13 , pp. 264-271
    • Irving, W.L.1    Smith, S.2    Cater, R.3
  • 6
    • 10644220356 scopus 로고    scopus 로고
    • The impact of injecting drug use status on hepatitis C-related referral and treatment
    • Stoove MA, Gifford SM, Dore GJ. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend 2005 77 : 81 86.
    • (2005) Drug Alcohol Depend , vol.77 , pp. 81-86
    • Stoove, M.A.1    Gifford, S.M.2    Dore, G.J.3
  • 7
    • 34047190908 scopus 로고    scopus 로고
    • Hepatitis C risk assessment, testing and referral for treatment in urban primary care: Role of race and ethnicity
    • Trooskin SB, Navarro VJ, Winn RJ et al. Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroenterol 2007 13 : 1074 1078.
    • (2007) World J Gastroenterol , vol.13 , pp. 1074-1078
    • Trooskin, S.B.1    Navarro, V.J.2    Winn, R.J.3
  • 8
    • 70350018996 scopus 로고    scopus 로고
    • Worrisome disposition of hepatitis C antibody positive patients
    • AbstractL0553.
    • Sarbah SA, Kim P, Levinthal GN et al. Worrisome disposition of hepatitis C antibody positive patients. Gastroenterology 1998 114 : Abstract L0553.
    • (1998) Gastroenterology , vol.114
    • Sarbah, S.A.1    Kim, P.2    Levinthal, G.N.3
  • 9
    • 70350024258 scopus 로고    scopus 로고
    • Comprehensive hepatitis empowerment program (C-HEP) improves awareness and follow-up across ethnic groups in patients with positive HCV antibody
    • Abstract6722.
    • Sarbah SA, Kaminsky-Russ K, Dasarathy S et al. Comprehensive hepatitis empowerment program (C-HEP) improves awareness and follow-up across ethnic groups in patients with positive HCV antibody. Gastroenterology 2000 118 : Abstract 6722.
    • (2000) Gastroenterology , vol.118
    • Sarbah, S.A.1    Kaminsky-Russ, K.2    Dasarathy, S.3
  • 10
    • 0036172811 scopus 로고    scopus 로고
    • Diagnosis and 10-year follow-up of a community-based hepatitis C cohort
    • Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002 51 : 135 140.
    • (2002) J Fam Pract , vol.51 , pp. 135-140
    • Yawn, B.P.1    Wollan, P.2    Gazzuola, L.3    Kim, W.R.4
  • 11
    • 0035039269 scopus 로고    scopus 로고
    • The epidemiology of hepatitis C in a UK health regional population of 5.12 million
    • Trent HCV Study Group.
    • Mohsen AH, Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001 48 : 707 713.
    • (2001) Gut , vol.48 , pp. 707-713
    • Mohsen, A.H.1
  • 12
    • 0042940185 scopus 로고    scopus 로고
    • Available at. . Accessed February 20, 2008.
    • U.S. Census 2000. Available at: http://www.census.gov/main/www/cen2000. html. Accessed February 20, 2008.
    • U.S. Census 2000
  • 13
    • 9644262441 scopus 로고    scopus 로고
    • Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
    • Zeuzem S, Diago M, Gane E et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004 127 : 1724 1732.
    • (2004) Gastroenterology , vol.127 , pp. 1724-1732
    • Zeuzem, S.1    Diago, M.2    Gane, E.3
  • 14
    • 2442665224 scopus 로고    scopus 로고
    • Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
    • DOI 10.1056/NEJMoa032502
    • Muir A, Bornstein JD, Killenberg PG. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004 350 : 2265 2271. (Pubitemid 38669209)
    • (2004) New England Journal of Medicine , vol.350 , Issue.22 , pp. 2265-2271
    • Muir, A.J.1    Bornstein, J.D.2    Killenberg, P.G.3
  • 16
    • 0032819161 scopus 로고    scopus 로고
    • Current practice patterns of primary care physicians in the management of patients with hepatitis C
    • Shehab TM, Sonnad SS, Jeffries M et al. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999 30 : 794 800.
    • (1999) Hepatology , vol.30 , pp. 794-800
    • Shehab, T.M.1    Sonnad, S.S.2    Jeffries, M.3
  • 17
    • 0035726250 scopus 로고    scopus 로고
    • Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey
    • Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001 8 : 377 383.
    • (2001) J Viral Hepat , vol.8 , pp. 377-383
    • Shehab, T.M.1    Sonnad, S.S.2    Lok, A.S.3
  • 18
    • 30044432484 scopus 로고    scopus 로고
    • American Gastroenterological Association Technical Review on the management of hepatitis C
    • Dienstag JL, McHutchison JG. American Gastroenterological Association Technical Review on the management of hepatitis C. Gastroenterology 2006 130 : 231 264.
    • (2006) Gastroenterology , vol.130 , pp. 231-264
    • Dienstag, J.L.1    McHutchison, J.G.2
  • 19
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • Strader DB, Wright T, Thomas DL et al. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004 39 : 1147 1171.
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.B.1    Wright, T.2    Thomas, D.L.3
  • 20
    • 85005773666 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
    • Persico M, Persico E, Suozzo R et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000 118 : 760 764.
    • (2000) Gastroenterology , vol.118 , pp. 760-764
    • Persico, M.1    Persico, E.2    Suozzo, R.3
  • 21
    • 33646121757 scopus 로고    scopus 로고
    • Chronic hepatitis C in patients with persistently normal alanine transaminase levels
    • Shiffman ML, Diago M, Tran A et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006 4 : 645 652.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 645-652
    • Shiffman, M.L.1    Diago, M.2    Tran, A.3
  • 22
    • 0035020530 scopus 로고    scopus 로고
    • Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples
    • Kessler HH, Stelzl E, Raggam RB et al. Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol 2001 39 : 1788 1790.
    • (2001) J Clin Microbiol , vol.39 , pp. 1788-1790
    • Kessler, H.H.1    Stelzl, E.2    Raggam, R.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.